US FDA reverses course, will review Moderna's modified flu vaccine application

Feb 18 () - Moderna said on Wednesday the U. Food and Drug Administration has agreed to review ‌its influenza vaccine, reversing an earlier decision to reject ‌the application, after the company made ...
STAT

FDA reverses course, agrees to review Moderna’s flu vaccine

The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced ...

Moderna gains as FDA backtracks and accepts flu shot for review

Moderna (MRNA) shares gained in the premarket on Wednesday after the U.S. FDA accepted the company’s marketing application ...

US FDA reverses course, will review Moderna's flu vaccine

The US Food and Drug Administration will now review Moderna's influenza vaccine. This comes after an initial refusal due to ...

Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial

The study involved 550 healthy U.S. adults ages 18 to 75 who received either the experimental combo vaccine and a placebo or ...

Moderna, Inc.: Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

Following a Type A meeting, the FDA's Center for Biologics Evaluation and Research has notified Moderna that its biologics license application for mRNA-1010 will proceed to reviewModerna has received ...

Wealthy Calif. county goes after sheriff's overtime

"Wouldn't that set off a bunch of flags in your budget system?" ...